Medical device manufacturers work and operate in various regulatory systems whose requirements are different and not always consistent with each other. The new ISO version, the ISO 13485:2016, recognizes this fact. The disparate requirements of each regulatory system make it necessary for manufacturers to identify their roles, as well as the regulatory requirements for that role, and then incorporate them into their Quality Management System.
The various jurisdictions, however, deal with post-market device issues in diverse ways. Complaint management, Adverse event reporting and Recalls are three interlocking and interrelated processes that need to go into the QMS.
Corrective action and design changes, which are supporting QMS processes; also need to complement these three processes. And then, the regulatory requirements, which usually involve areas such as recordkeeping and reporting, also come in.
A course on how to implement an integrated QMS
GlobalCompliancePanel, a leading provider of professional trainings for all the areas of regulatory compliance, is organizing a highly educative and valuable learning session on these primary and secondary QMS processes and the way they need to be understood and implemented in relation to the US, EU, and Canadian regulations.
Dan O’Leary, who is President of Ombu Enterprises, LLC, a company offering training and execution in Operational Excellence, which focuses on analytic skills and a systems approach to operations management, will be the Director of this two-day seminar. Dan brings more than 30 years’ experience in quality, operations, and program management in regulated industries including aviation, defense, medical devices, and clinical labs.
Want to benefit from Dan’s rich experience and want to understand the way in which to implement an integrated QMS in which the various aspects of complaints, adverse reporting and recalls are built? Please register for this seminar by visiting Complaints Handling, Adverse Event Reporting, and Recalls call for .... This seminar has been pre-approved by RAPS as eligible for up to 12 credits towards a participant’s RAC recertification upon full completion.
Alignment with the FDA’s QMS
The extent of its alignment with the FDA’s Quality Management System (QMS) requirement is one of the highlights of the final version of the ISO 13485:2016 standard, which has now become available. The degree of alignment set out in 2016 version of 13485 may be significantly higher than that of the previous version of 2003; yet, there still do exist a few points at which it deviates from the FDA’s QMS. Companies that should comply with this standard have to keep this in mind.
Now that the ISO 13485:2016, the Medical Device Single Audit Program (MDSAP), and the new EU Medical Device Regulation have been introduced; companies need to update their QMS and integrate all of the elements if their implementation has to be effective and compliant. At this two-day session, Dan will provide the tools that the participants will need for this.
Upset man lost in thought having received bad news from his doctorThe agenda of this learning session will be the following:
- The Regulatory Structure
- FDA QSR
- ISO 13485:2016 and regional variants
- ISO 14971:2007 and regional variants
- Implementing MDSAP
- The EU Medical Device Regulation
- Servicing
- Identification of problems
- Servicing data analysis
- Input to the complaint process
- Complaints
Identifying complaints
- Evaluating complaints
- Investigating complaints
- Complaint data analysis
- Input to the corrective action process
- Input to the risk management process
- Corrective Action
- Developing the process
- Analyzing product and process information
- Determining subsequent actions
- Input to the design process
- Input to the risk management process
- Design and Design Changes
- Determining the need for a design change
- Documenting design changes
- Design change verification and validation
- Input to the risk management process
- Input to the pre-market submission process
- Risk Management
- ISO 14971:2007 and regional variants
- Incorporating post-market information
- Updating Pre-market Submissions
- US – The 510(k) guidance
- EU – Technical files and design dossiers
- Canada – License changes
- Adverse Event Reporting
- US – MDR
- EU – Vigilance Reports
- Canada – Mandatory Problem Reporting
- Recalls
- US – Corrections and Removals
- EU – Field Safety Corrective Actions
- Canada – Recall.
You need to be a member of MedTech I.Q. to add comments!
Join MedTech I.Q.